Pharma Company Bags New Rs 44 Crore Order From United Nations International Children's Emergency Fund (UNICEF) Pharma Company Bags New Rs 44 Crore Order From United Nations International Children's Emergency Fund (UNICEF) The company has a market cap of over Rs 3,000 crore and the stock gave multibagger returns of 382 per cent from its 52-week low of Rs 112.35 per share. DSIJ Intelligence-1 / Thursday, April 24, 2025 0 194 Article rating: 3.3 The company has a market cap of over Rs 3,000 crore and the stock gave multibagger returns of 382 per cent from its 52-week low of Rs 112.35 per share. Read more
Eugia Pharma receives USFDA Approval for Dasatinib Tablets Eugia Pharma receives USFDA Approval for Dasatinib Tablets The company has a market cap of over Rs 70,000 crore and the stock is up by 23 per cent from its 52-week low of Rs 994.35 per share. DSIJ Intelligence-1 / Wednesday, April 23, 2025 0 143 Article rating: 5.0 The company has a market cap of over Rs 70,000 crore and the stock is up by 23 per cent from its 52-week low of Rs 994.35 per share. Read more
Pharmaceuticals Company Gets USFDA Approval For Phytonadione Injectable Emulsion Pharmaceuticals Company Gets USFDA Approval For Phytonadione Injectable Emulsion The stock gave multibagger returns of 190 per cent in 2 years and a whopping 500 per cent in 5 years. DSIJ Intelligence-1 / Wednesday, April 23, 2025 0 206 Article rating: 4.6 The stock gave multibagger returns of 190 per cent in 2 years and a whopping 500 per cent in 5 years. Read more
Kiran Mazumdar Shaw-Backed Pharma Company is Likely to Raise Funds by Way of Issue of Equity Shares Kiran Mazumdar Shaw-Backed Pharma Company is Likely to Raise Funds by Way of Issue of Equity Shares The company has been maintaining a healthy dividend payout of 18 per cent. DSIJ Intelligence-1 / Sunday, April 20, 2025 0 395 Article rating: 3.6 The company has a market cap of Rs 39,728 crore where Kiran Mazumdar Shaw (promoter of the company) holds a 40.36 per cent stake in the company. Read more
Pharma Company Has Received Final Approval From United States Food and Drug Administration For Abbreviated New Drug Application Pharma Company Has Received Final Approval From United States Food and Drug Administration For Abbreviated New Drug Application The company has a market cap of over Rs 1 lakh crore and the stock is up by 13 per cent from its 52-week low of Rs 1,310.05 per share. DSIJ Intelligence-1 / Sunday, April 13, 2025 0 428 Article rating: 4.7 The company has a market cap of over Rs 1 lakh crore and the stock is up by 13 per cent from its 52-week low of Rs 1,310.05 per share. Read more